glp1gradedGLP-1 provider ratings

Grade notice. No grade is published anywhere on this site: the weights are provisional and are not signed off, so no letter grade, weighted total or ranking appears on any page.

Harbor

Harbor publishes 3 rankable monthly figures and not one of them says what dose it buys. This site prints no comparable figure for Harbor, and the reading behind that is on this page.

Ellis Brandt built this site’s grading methodology and maintains it. Last re-read September 2026.

The figures this seller publishes

Harbor publishes 3 rankable monthly figures for semaglutide and tirzepatide. This site prints no comparable figure for Harbor, because a figure that does not say what dose it buys cannot be compared with one that does. What follows is what was read, in the words of the person who read it.

Tirzepatide — reading 1 of 2

The seller ties no dose to this figure.

No mg appears anywhere on the page. Caution: There IS a flat-price statement here — 'Flat as your dose goes up, no price increases' and 'Flat pricing. No price increases as your dose goes up.' — but both are printed inside the SEMAGLUTIDE PROGRAM card and the semaglutide hero, and this $119 figure is the tirzepatide cross-link block ('PREFER TIRZEPATIDE? / Tirzepatide / $119/mo'), which carries no dose or pricing language of its own. Pharmacy and dose facts are drug-scoped, so I will not carry the semaglutide flat claim onto the tirzepatide figure. Separately: the pass-3 note on this offer reads the page as saying 'price increases as your dose goes up' — that is an inversion; the page says the opposite.

The page never says what the figure covers. Read September 2026 from https://visitharbor.com/semaglutide.

Tirzepatide — reading 2 of 2

The seller ties no dose to this figure.

No mg appears anywhere on the page. This figure comes from the footer product list ('Tirzepatide / $149/mo / Dual-action GLP-1/GIP for accelerated results'), which carries no dose language at all. It also contradicts the $119/mo tirzepatide figure printed in the body of the same page.

The page never says what the figure covers. Read September 2026 from https://visitharbor.com/semaglutide.

Semaglutide

The seller ties no dose to this figure.

No mg anywhere on the page. This is the footer product-list entry 'Semaglutide / $99/mo / GLP-1 for steady results' — no dose language attached. Worth flagging: the same footer list prints $99/mo twice more, for Sermorelin and NAD+, which are not GLP-1s, and $99/mo also contradicts the page's own 'From $89/mo' hero and its '$89 /mo' SEMAGLUTIDE PROGRAM card.

The page never says what the figure covers. Read September 2026 from https://visitharbor.com/semaglutide.

What the page states, and what it leaves out

Talks about pharmacies and names none. No figure this seller publishes states what it buys, so no price is printed here.

Cancellation

Cancellation terms have not been read for Harbor. The pass that opened, timed and recorded cancellation terms covered the 60 sellers whose figure states what it buys, and Harbor is not one of them. This site therefore states nothing about how Harbor handles cancellation — not that terms are absent, only that we have not read them. It is a gap in this site’s reading, and it is recorded as one rather than scored as a silence.

Dose escalation

This seller does not print the titration steps its patients follow. 54 of the 60 sellers whose figure states what it buys do not either. What the four FDA-approved labels set as the escalation is published on this site with no provider named and no paid link.

Go to Harbor

Harbor pays this site nothing. The link below is unpaid and carries no tracking of any kind. It goes to the page that carries the figure quoted above.

Visit site

Where this seller is listed

One board per buying decision. Each is the same table with the columns that decision needs, under its own dated and counted title.

Every seller we have read